Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering-Reference-Cited by-同舟云学术

Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering

Published:2021-12-01 Issue:12 Volume:6 Page:1397
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Berry Jarett D.¹,Nambi Vijay²,Ambrosius Walter T.³,Chen Haiying³,Killeen Anthony A.⁴,Taylor Addison⁵,Toto Robert D.¹,Soliman Elsayed Z.⁶⁷,McEvoy John W.⁸,Pandey Ambarish¹,Joshi Parag H.¹,Blankenberg Stefan⁹,Kitzman Dalane W.¹⁰¹¹,Ballantyne Christie M.¹²,de Lemos James A.¹

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas

2. Michael E. DeBakey Veterans Affairs Hospital, Baylor College of Medicine, Houston, Texas

3. Division of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina

4. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis

5. Department of Medicine, Baylor College of Medicine, Houston, Texas

6. Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston Salem, North Carolina

7. Cardiology Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina

8. National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland

9. Department of General and Interventional Cardiology, University Heart Center Hamburg, German Center for Cardiovascular Research, partner site Hamburg/Kiel/Luebeck, Hamburg, Germany

10. Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

11. Section on Geriatrics, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

12. Center for Cardiometabolic Disease Prevention, Department of Medicine, Baylor College of Medicine, Houston, Texas

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2783497/jamacardiology_berry_2021_oi_210058_1637772540.9484.pdf

Reference29 articles.

1. Multimodality strategy for cardiovascular risk assessment: performance in 2 population-based cohorts.;de Lemos;Circulation,2017

2. A sensitive cardiac troponin T assay in stable coronary artery disease.;Omland;N Engl J Med,2009

3. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.;Omland;J Am Coll Cardiol,2007

4. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.;Willeit;Lancet Diabetes Endocrinol,2016

5. Biomarkers and clinical cardiovascular outcomes with ezetimibe in the IMPROVE-IT Trial.;Qamar;J Am Coll Cardiol,2019

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT;Hypertension;2024-09

2. Modeling the Impact of Biomarker-Guided Versus ASCVD Risk–Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004;Hypertension;2024-07

3. Prognostic Value of Cardiovascular Biomarkers in the Population;JAMA;2024-06-11

4. Systolic Blood Pressure, Diastolic Blood Pressure and Pulse Pressure and the Risk of Subclinical Myocardial Injury: The HUNT Study;Journal of the American Heart Association;2024-05-07

5. The lowest well tolerated blood pressure: A personalized target for all?;European Journal of Internal Medicine;2024-05